Editorial: Proteomics of Microbial Human Pathogens by Nelson C. Soares et al.
EDITORIAL
published: 04 November 2016
doi: 10.3389/fmicb.2016.01742
Frontiers in Microbiology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 1742
Edited by:
Marc Strous,
University of Calgary, Canada
Reviewed by:
Nadeem Omar Kaakoush,
University of New South Wales,
Australia
*Correspondence:
Nelson C. Soares
nelson.dacruzsoare@uct.ac.za
Specialty section:
This article was submitted to
Microbial Physiology and Metabolism,
a section of the journal
Frontiers in Microbiology
Received: 26 August 2016
Accepted: 18 October 2016
Published: 04 November 2016
Citation:
Soares NC, Bou G and Blackburn JM
(2016) Editorial: Proteomics of
Microbial Human Pathogens.
Front. Microbiol. 7:1742.
doi: 10.3389/fmicb.2016.01742
Editorial: Proteomics of Microbial
Human Pathogens
Nelson C. Soares 1*, German Bou 2 and Jonathan M. Blackburn 1
1Division of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences,
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, 2 Servicio de
Microbiologia-Instituto de Investigación Biomédica, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
Keywords: proteomics, mass spectrometry, microbes, bacteria, virulence, pathogens, protein posttranslational
modifications
The Editorial on the Research Topic
Proteomics of Microbial Human Pathogens
Despite remarkable advances in treatment and prevention, infectious diseases remain amongst
the leading causes of death worldwide, particularly in the developing world, and drug resistant
pathogens are ominously on the rise. By way of one specific example, the global incidence of human
tuberculosis (TB) disease—caused by infection with the pathogen Mycobacterium tuberculosis—is
estimated to be ∼9 million new cases (∼0.1% of the global population) per annum, causing 1.5–2
million deaths per annum and with an estimated 450,000 people developing multi-drug resistant
tuberculosis each year); moreover, the WHO estimates that ∼1/3rd of the World’s population
carries a latent M. tuberculosis infection, thus representing a huge reservoir of potential future
TB cases. In the context of this Research Topic, it is also relevant that the burden of TB disease
is very uneven globally, with certain countries in Africa having a much higher incidence than
observed in the developed world—for example, in South Africa the national incidence of TB disease
is around 1% of the population and a single city, Cape Town, reports more cases of TB annually
than the whole of North America and Europe combined. Furthermore, roughly 21% of all deaths in
South Africa are associated with TB disease today, despite proactive efforts at TB control since the
beginning of the twentieth century and despite the TB control program in Cape Town achieving
75% case finding and 85% completion rates for smear positive disease. Similarly depressing statistics
abound for numerous other infectious diseases in the developing world, with disease burden being
driven by both microbial adaption (to drug resistance and to differing ecologies), as well as by the
emergence of new, often zoonotic pathogens (e.g., ebola and zika viruses). According to the World
Health Organization (WHO), infectious diseases today account for more than 70% of premature
deaths across 22 African countries (Who, 2014), with co-infections, for example with HIV or
helminths, being rife. It is therefore critical that we develop new molecular knowledge now that
will inform new strategies in the global fight against human microbial pathogens—including those
that are not prevalent in the developed world—with the use of state-of-the art “omics” technologies
set to take center-stage through providing a detailed understanding of the mechanistic basis of
pathogenicity and by creating a comprehensive description of themolecular interplays that mediate
host-pathogen interactions.
During the last two decades, powerful high throughput research platforms—namely genomics,
transcriptomics, and proteomics—have contributed significantly to our understanding of the life
styles of pathogenic microbes, including important aspects of host interactions and infection
(Raskin et al., 2006; Merhej et al., 2013; Yang et al., 2015). Of all the omics platforms,
proteomics is perhaps the research platform that has undergone the greatest transformation,
including a structural transformation, as it evolved from initial two-dimensional gel
electrophoresis (2-DE gel) based workflows to sophisticated shotgun proteomics analysis, capable
Soares et al. Editorial: Proteomics of Microbial Human pathogens
of generating comprehensive data with a coverage of individual
proteomes that begins to approach that of corresponding
genomics/transcriptomics datasets now. Modern mass
spectrometry (MS)-based approaches today enable the detection
and relative/absolute quantification of several thousand proteins
in a single run, providing the opportunity to make a major
impact on our general understanding of microbial pathogens.
The goal of this Research Topic is thus to provide a survey of
recent mass spectrometry-based research on the proteomics
of human pathogens, which term we use broadly to refer to
microorganisms that cause disease in humans, including inter
alia virus, bacteria, fungi, and protozoa.
In this Research topic, we have particularly sought to
highlight the powerful synergies that can be found between
the fields of proteomics and microbiology, as exemplified by
the review of Baarda and Sikora, which outlines the treasure
hunt for counter-measures against old disease (Baarda and
Sikora). Their review starts by acknowledging early contributions
of 2-DE gel approaches, and how this approach implicated
novel proteins—such as peroxidoxin, outer membrane protein
Rmp, and the 50S ribosomal proteins L7/L12—in the Neisseria
gonorrhoeae acquired resistance to spectinomycin. They then
highlight how the employment of recent quantitative proteomics
(SILAC, iTRAQ, and iCAT) has illuminated the pathways utilized
by N. gonorrhoeae to adapt to different lifestyles, including
during host interaction itself. A similar trend, suggesting that
progression in the field of proteomics strongly augments classical
microbiological research on microbial pathogens, is also evident
in several others reviews (Ravikumar et al.; Pérez -Llarena and
Bou; Soufi and Soufi), as well as opinion articles, in this Research
Topic (Soares and Blackburn).
Elsewhere in this Research Topic, Perez-Llarena and Bou
describe proteomics as a tool to study bacterial virulence
(Pérez-Llarena and Bou) and, following this lead, this
Research Topic carries several original reports that employ
proteomics based approaches to investigate different aspects of
bacterial/fungi virulence, including biofilm formation (Arnal
et al.), motility (Merino et al.), virulence factors (Diehl et al.),
altered virulence between strains (Peters et al.), and determinants
that mediate host interaction in Candida albicans (Marin et al.).
For example, Peters et al. used a combination of discovery and
targeted liquid chromatography-tandem mass spectrometry
(LC-MS/MS)-based proteomics to compare the proteomes
of six clinically relevant mycobacterial strains within the M.
tuberculosis complex (MTBC) (Peters et al.); MTBC members
show a high degree of genetic conservation (∼99.9%), yet
clinically they exhibit differing pathogenicity and virulence.
Peters et al. identified an average of 3290 protein groups for
each MTBC organism, corresponding to >80% coverage of
the theoretical proteomes; thereafter, the authors identified
quantitative differences between strains for specific proteins that
could be linked to enhanced bacterial fitness in the more virulent
W. Beijing lineage ofM. tuberculosis (Peters et al.).
This Research Topic also includes a number of manuscripts
that explore novel applications of mass spectrometry within
microbial research (Hartmann et al.); (Potgieter et al.); (Soares
and Blackburn) (Soufi and Soufi), providing evidence that
proteomics has now evolved into a robust platform capable
of generating comprehensive datasets comparable in size and
utility to those described in genomic studies and enabling the
application of mass spectrometry-based proteomics to genome
reannotation and refinement (Krug et al., 2011). For example, in
this topic, Potgieter et al. report the results of a proteogenomic
analysis of M. smegmatis, integrating mass spectrometry-based
proteomics with genomic six frame translation and ab initio gene
prediction databases to identify a total of 2887 open reading
frames (ORFs), including 2810 ORFs previously annotated to a
reference protein and 63 ORFs not previously annotated to any
reference protein (Potgieter et al.).
Finally, several papers in this Research Topic have described
the enormous contribution of proteomics to the knowledge-
based regarding bacterial protein post translation modifications
(PTMs) and their intimate association with virulence (Ravikumar
et al.); (Calder et al.); (Pérez -Llarena and Bou); (Soares and
Blackburn); (Soufi and Soufi) and it will be interesting to
see whether future investigation of bacterial PTMs provide a
means to discover targets for novel therapies (Soufi and Soufi).
In an Opinion article, we challenge researchers in the field
to join efforts and to take advantage of recent advances in
mass spectrometry instrumentation and in the development
of targeted quantitative workflows that enable detection and
accurate quantification of bacterial PTMs (Soares and Blackburn)
since we believe that this represents a golden opportunity to
access the dynamics of bacterial PTMs at sites of infection and
that, through this, researchers will gain meaningful insights
into the functional role of such PTMs during host-pathogen
interactions.
CONCLUSION
Overall, this Research Topic demonstrates the huge potential for
modern mass spectrometry-based (phospho)proteomics to yield
major breakthroughs in our understanding of host-pathogen
interactions. Therefore, it seems reasonable to suppose that as
proteomics-based experimentation is married ever more closely
with biologically relevant models of human microbial disease,
the analytical power of quantitative mass spectrometry will
yield testable hypotheses about key molecular host-pathogen
interactions and might identify new candidate drug or vaccine
targets. However, in order to reach this Holy Grail, the
burgeoning microbial proteomics field will need to not only
infer but then experimentally validate true biological significance
from amongst the vast datasets generated. Tighter integration
and iteration between computational modeling of proteomic data
and model-driven further experimentation, including use of cell
biology, imaging and CRISPR technologies therefore seems likely
to represent the future.
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